Full video transcriptClick to expand
Auto-generated transcript of @onehottrail's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00So there's a new peptide in the market that can increase the size of your little friend down there.
- 0:03And this Chinese research team has just discovered it.
- 0:05Let's look at the results.
- 0:06You got a 25% increase within four weeks.
- 0:09That's like an inch to an inch and a quarter for these Chinese people.
- 0:11Row away your pumps boys,
- 0:13because a new peptide just dropped that makes you start growing like you're going through puberty again.
- 0:17The name of it is Pubertide 2, and unfortunately, it's not real.
- 0:22So keep your pump close.
- 0:24You see, I spent a good portion of my day looking for the study.
- 0:27You know, for people who need it, because I'm good until I eventually realized it was a joke.
- 0:32But all hope for those who need it is not lost.
- 0:34Because there are other methods which I've covered that do actually work.
- 0:38For example, using a high tension or a low tension extender for length and pumping for girth.
- 0:43Annual stretching also works for length, but it's just not as convenient as using a device.
- 0:49And no, they aren't side effects free, especially if you're not doing it properly.
- 0:53Some of the side effects include discoloration, pain, numbness, and also blisters.
- 0:57If you go too high in the vacuum device, or if you use a vacuum cup improperly, but they do work nonetheless.
Can peptides actually increase penis size? What the science says
Quick answer
Penile traction therapy has limited but real clinical support for modest length gains in men with Peyronie's disease or post-surgical tissue changes, per a 2011 BJUI study by Gontero et al., but outcomes vary and require consistent long-term use. Vacuum erection devices have stronger evidence for erectile rehabilitation than for cosmetic enlargement, and misuse carries documented injury risks including ischemia and nerve compression. No peptide therapy, including any growth hormone secretagogue currently available through compounding, has demonstrated genital tissue growth in peer-reviewed human trials.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Can peptides actually increase penis size? What the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Can peptides actually increase penis size? What the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Can peptides actually increase penis size? What the science says" from OneHot. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Penile traction therapy has limited but real clinical support for modest length gains in men with Peyronie's disease or post-surgical tissue changes, per a 2011 BJUI study by Gontero et al.
The reason this review is not generic is the source wording and the canonical claim label "peptides new peptide to help increase your size lastofthenattys dihma." In this clip, the useful excerpt is: "So there's a new peptide in the market that can increase the size of your little friend down there." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Penile traction therapy has limited but real clinical support for modest length gains in men with Peyronie's disease or post-surgical tissue changes, per a 2011 BJUI study by Gontero et al.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Penile traction therapy has limited but real clinical support for modest length gains in men with Peyronie's disease or post-surgical tissue changes, per a 2011 BJUI study by Gontero et al., but outcomes vary and require consistent long-term use. Vacuum erection devices have stronger evidence for erectile rehabilitation than for cosmetic enlargement, and misuse carries documented injury risks including ischemia and nerve compression. No peptide therapy, including any growth hormone secretagogue currently available through compounding, has demonstrated genital tissue growth in peer-reviewed human trials.
- "Pubertide 2" is a fictional peptide. No compound in compounding pharmacies or clinical development has demonstrated penile tissue growth in humans.
- Gontero et al. (2011, BJUI) found traction therapy produced measurable but modest length gains, requiring approximately six hours of daily wear over several months.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- "Pubertide 2" is a fictional peptide. No compound in compounding pharmacies or clinical development has demonstrated penile tissue growth in humans.
- Gontero et al. (2011, BJUI) found traction therapy produced measurable but modest length gains, requiring approximately six hours of daily wear over several months.
- Vacuum erection devices have FDA-cleared indications for erectile rehabilitation, not cosmetic enlargement. Using consumer pumps for cosmetic purposes falls outside that evidence base.
- Documented side effects of improper vacuum pump use include ischemia, nerve compression, discoloration, and blistering. Numbness during a session is a stop signal, not a minor inconvenience.
- No growth hormone secretagogue peptide, including ipamorelin, CJC-1295, or MK-677, has peer-reviewed human data linking it to genital tissue enlargement.
- Manual stretching has almost no randomized controlled trial support for cosmetic use, though it appears as adjunct therapy in some Peyronie's disease protocols.
- The creator's side effect disclosure was more responsible than most content in this category. Transparency about risks is a floor, not a ceiling, but it counts.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @onehottrail actually say?
The creator opened with a hook about a fictional peptide called "Pubertide 2" that supposedly causes "25% increase within four weeks," then admitted mid-video it was a joke. Credit where it's due: he came clean. The second half shifted to real methods, including traction extenders, vacuum pumps, and manual stretching, with a candid warning that side effects are real when these devices are misused.
The video is essentially a bait-and-switch that pivots from satire into a genuine, if brief, review of penis enlargement methods that have actual clinical data behind them. The framing was honest. The pivot was handled better than most TikTok health content manages.
Does the science back this up?
On the real methods, yes, partially. Penile traction therapy has the most legitimate evidence. A 2011 study by Gontero et al. in the British Journal of Urology International found modest but measurable gains in stretched flaccid length with consistent traction device use. Vacuum erection devices have a longer clinical track record, primarily for erectile rehabilitation after prostate surgery, not cosmetic girth gains, but some urologists do use them off-label for tissue conditioning.
Manual stretching has almost no rigorous randomized controlled trial data. The creator is correct that it works less conveniently, but calling it effective without qualification oversimplifies a thin evidence base. The side effects he listed, including discoloration, pain, numbness, and blisters, are well-documented in the literature, particularly for high-pressure vacuum use. He was right to name them.
What did they get wrong (or right)?
He got the side effect disclosure right, and that matters. Most creators pushing these methods online skip that part entirely.
What he got wrong, or at least left dangerously vague: there is a meaningful difference between vacuum devices used for erectile rehabilitation under medical supervision and consumer pump devices bought online for cosmetic use. Conflating those two contexts can lead users to apply clinical-adjacent logic to unregulated hardware. Saying "they do work nonetheless" without specifying what outcomes were measured, in which populations, and under what conditions is the kind of shortcut that misleads a 465K-person audience.
Also worth noting: no peptide currently in clinical development or compounding pharmacies has demonstrated penile tissue growth in humans. Growth hormone secretagogues like ipamorelin or CJC-1295 are sometimes stacked with speculative body recomposition goals, but there is no peer-reviewed human data connecting any peptide to genital tissue enlargement.
What should you actually know?
If you're considering traction therapy, the evidence is modest and the commitment is significant. Gontero et al. required six hours of daily wear over six months for measurable results. That is not the same as an "inch to an inch and a quarter in four weeks" that the fictional Pubertide 2 was satirizing, but the contrast is the point.
Vacuum pump misuse is a real clinical problem. Emergency urologists see penile injury from improper vacuum use more often than most men realize. Pressure limits, session duration, and device quality all matter. Numbness and discoloration are early warning signs that should stop a session immediately, not be pushed through.
If you're approaching any of this from a telehealth context, a licensed provider can discuss FDA-cleared traction devices and evidence-based protocols. A TikTok video, even a well-intentioned one, is not a treatment plan.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
OneHot · TikTok creator
465.8K views on this video
New peptide to help increase your size? #lastofthenattys #dihmaxxing #dihfluencer #dihmax #menshealthtips
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about "pubertide 2"?
"Pubertide 2" is a fictional peptide. No compound in compounding pharmacies or clinical development has demonstrated penile tissue growth in humans.
What does the video say about gontero et al. (2011, bjui) found traction therapy produced measurable?
Gontero et al. (2011, BJUI) found traction therapy produced measurable but modest length gains, requiring approximately six hours of daily wear over several months.
What does the video say about vacuum erection devices have fda-cleared indications for erectile rehabilitation, not?
Vacuum erection devices have FDA-cleared indications for erectile rehabilitation, not cosmetic enlargement. Using consumer pumps for cosmetic purposes falls outside that evidence base.
Documented side effects of improper vacuum pump use include ischemia, nerve compression, discoloration, and blistering. Numbness during a session is a stop signal, not a minor inconvenience?
Documented side effects of improper vacuum pump use include ischemia, nerve compression, discoloration, and blistering. Numbness during a session is a stop signal, not a minor inconvenience.
What does the video say about no growth hormone secretagogue peptide, including ipamorelin, cjc-1295,?
No growth hormone secretagogue peptide, including ipamorelin, CJC-1295, or MK-677, has peer-reviewed human data linking it to genital tissue enlargement.
What does the video say about manual stretching has almost no randomized controlled trial support for?
Manual stretching has almost no randomized controlled trial support for cosmetic use, though it appears as adjunct therapy in some Peyronie's disease protocols.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by OneHot, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.